Publications by authors named "Davey Daniel"

Claim this Profile
I
Impact of community recruitment and inclusion initiatives on enrollment in the biomarker-driven MyTACTIC trial.
Richard M Zuniga, Ari VanderWalde, Lee S Schwartzberg, David R Spigel, Luke Passler, Davey Daniel

Future Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rising tide lifts all boats in the personalized cancer care continuum for mNSCLC: bridging inequities in NGS fosters equity in targeted treatment.
Victor T G Lin, Esprit Ma, Neha Jain, Zhiyu Xia, Danny Sheinson, Davey Daniel

Oncologist· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.
Ying Cheng, David R Spigel, Byoung Chul Cho, Konstantin K Laktionov, Jian Fang, Davey B Daniel

N Engl J Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.
Thomas Stricker, Neha Jain, Esprit Ma, Elaine Yu, Rongrong Wang, Daniel Vaena, Davey Daniel

Oncologist· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in the US Community Setting.
Gregory A Vidal, Neha Jain, Aaron Fisher, Daniel Sheinson, Katherine T Lofgren, Davey Daniel

JCO Oncol Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC.
Johan F Vansteenkiste, Jarushka Naidoo, Corinne Faivre-Finn, Mustafa Özgüroğlu, Augusto Villegas, Davey Daniel

JTO Clin Res Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial.
Tina Cascone, Gozde Kar, Jonathan D Spicer, Rosario García-Campelo, Walter Weder, Davey B Daniel

Cancer Discov· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.
Lee Schwartzberg, Davey Daniel, Daniel Vaena, Dennis Slater, Harry Staszewski

Future Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC.
Lee S Schwartzberg, Gerald Li, Khaled Tolba, Ariel B Bourla, Katja Schulze, Davey Daniel

JTO Clin Res Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
Denise A Yardley, Robyn R Young, Kerin B Adelson, Andrea L Silber, Jose E Najera, Davey B Daniel

Clin Breast Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.
Ray D Page, Leylah M Drusbosky, Hiba Dada, Victoria M Raymond, Davey B Daniel, Daniel Dix

Clin Lung Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body Mass and Body Composition Changes over 7 Years in a Male Professional Rugby Union Team.
Clíodhna McHugh, Karen Hind, Aoife O'Halloran, Daniel Davey, Gareth Farrell

Int J Sports Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC).
Mark A Socinski, Mustafa Özgüroğlu, Augusto Villegas, Davey Daniel, David Vicente

Clin Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increases in DXA-Derived Visceral Fat Across One Season in Professional Rugby Union Players: Importance of Visceral Fat Monitoring in Athlete Body Composition Assessment.
Cliodhna McHugh, Karen Hind, Jason Wyse, Daniel Davey, Fiona Wilson

J Clin Densitom· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies.
Jared Weiss, Jerome Goldschmidt, Zoran Andric, Konstantin H Dragnev, Chad Gwaltney, Davey Daniel

Clin Lung Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.
Davey Daniel, Vladimer Kuchava, Igor Bondarenko, Oleksandr Ivashchuk, Sreekanth Reddy

Int J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer.
Marina C Garassino, Luis Paz-Ares, Rina Hui, Corinne Faivre-Finn, Alex Spira, Davey Daniel

Future Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.
David R Spigel, Robert M Jotte, Santiago Ponce Aix, Laurent Gressot, Daniel Morgensztern, Davey Daniel

Clin Lung Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC).
Corinne Faivre-Finn, David R Spigel, Suresh Senan, Corey Langer, Bradford A Perez, Davey Daniel

Lung Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Study: Transition to a Vegan Diet in an Elite Male Gaelic Football Player.
Daniel Davey, Shane Malone, Brendan Egan

Sports (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.
David M Waterhouse, Edward B Garon, Jason Chandler, Michael McCleod, Maen Hussein, Davey B Daniel

J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A career in sport does not eliminate risk of cardiovascular disease: A systematic review and meta-analysis of the cardiovascular health of field-based athletes.
Cliodhna McHugh, Karen Hind, Joice Cunningham, Daniel Davey, Fiona Wilson

J Sci Med Sport· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.
Sara Bedrose, Kevin Charles Miller, Lina Altameemi, Mohamed S Ali, Sameh Nassar, Davey B Daniel

J Immunother Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC.
Jhanelle E Gray, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami

J Thorac Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Rina Hui, Mustafa Özgüroğlu, Augusto Villegas, Davey Daniel, David Vicente

Lancet Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis